Question

Difficulty: EasyMonitoring and Treatment Evaluation

An overweight 55-year-old female visits the ambulatory care clinic for a scheduled blood pressure check. Two weeks ago, she was diagnosed with primary hypertension and prescribed daily oral losartan. Her baseline serum creatinine was 0.9 mg/dL0.9 \text{ mg/dL} and serum potassium was 4.2 mEq/L4.2 \text{ mEq/L}. Today, she feels well and denies any dizziness, headache, or edema. Her blood pressure is 128/78 mmHg128/78 \text{ mmHg}. Repeat laboratory testing shows a serum creatinine of 1.1 mg/dL1.1 \text{ mg/dL} and a serum potassium of 4.6 mEq/L4.6 \text{ mEq/L}. Which of the following are the most appropriate next steps in monitoring and treatment evaluation? (Select two)

  1. Continue the current dose of losartanAnswer
  2. Schedule a routine clinical follow-up in 4 weeksAnswer
  3. C
    Discontinue the losartan and switch to a calcium channel blocker
  4. D
    Order a renal artery duplex ultrasound
  5. E
    Add spironolactone to optimize blood pressure control

Answer

Continue the current dose of losartan AND schedule a routine clinical follow-up in 4 weeks.
Angiotensin II receptor blockers (ARBs) such as losartan exert their antihypertensive effect partly by dilating the efferent arteriole in the kidney. This decreases intraglomerular pressure, which commonly leads to a benign, expected rise in serum creatinine of up to 30% from baseline. In this patient, the creatinine increased from 0.9 mg/dL0.9 \text{ mg/dL} to 1.1 mg/dL1.1 \text{ mg/dL}, an increase of approximately 22%, which is well within the acceptable physiologic threshold. Furthermore, her serum potassium remains safely within normal limits (4.6 mEq/L4.6 \text{ mEq/L}), and her blood pressure has reached an excellent therapeutic target (128/78 mmHg128/78 \text{ mmHg}). Therefore, the most appropriate management is to continue the current effective medication regimen without any dose adjustments and schedule a routine follow-up appointment in approximately 4 weeks to ensure continued stability.

Step-by-Step Solution

1
Evaluate the patient's clinical and hemodynamic response to the prescribed losartan.
The patient is asymptomatic and her blood pressure is well-controlled at 128/78 mmHg128/78 \text{ mmHg}.
Determines if antihypertensive efficacy has been achieved.
2
Analyze the follow-up basic metabolic panel for potential adverse medication effects.
Creatinine increased by approximately 22% (from 0.9 mg/dL0.9 \text{ mg/dL} to 1.1 mg/dL1.1 \text{ mg/dL}) and potassium increased slightly to 4.6 mEq/L4.6 \text{ mEq/L}.
Angiotensin II receptor blockers (ARBs) can cause hyperkalemia and functional changes in the kidneys.
3
Determine the clinical significance of the observed laboratory changes.
The changes are within acceptable and safe limits. A serum creatinine increase of up to 30% from baseline is an expected physiologic response.
Misinterpreting this expected benign change could lead to inappropriate discontinuation of a highly effective medication.

Key Concept

Expected physiologic laboratory changes during ACE inhibitor or ARB initiation.
Rate this question